SCHEMBL6779923

SCHEMBL6779923

Cc1ccc2c(c1)CS(=O)(=O)c1cc(C(=O)NC(=N)NOC=O)c(C)cc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784567 0.92
SCHEMBL6779610 0.91 KMT2A (0.35)
SCHEMBL6784211 0.90 MAPT (0.34)
SCHEMBL6779341 0.89 KDM4E (0.32)
Formic Acid SCHEMBL6779916 0.85 KLK1 (0.32)
SCHEMBL6778741 0.85
SCHEMBL6780304 0.85 KMT2A (0.33)
SCHEMBL14341805 0.85 F2 (0.33)
SCHEMBL6780092 0.85
SCHEMBL6783272 0.80 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730697-B2 FOR USE AS ANTIARRYTHMIC MEDICAMENTS WITH A CARDIOPROTECTIVE COMPONENT FOR PROPHYLAXIS OF AN INFARCTION AND THERAPY OF INFARCTION, AND FOR TREATMENT OF ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-05-04 US disclosed
US-20030181511-A1 Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2003-09-25 US disclosed